Related Experiment Video
Updated: Apr 10, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Antibodies to Pseudogymnoascus destructans are not sufficient for protection against white-nose syndrome
Joseph S Johnson1, DeeAnn M Reeder1, Thomas M Lilley2
1Department of Biology, Bucknell University Lewisburg, Pennsylvania, 17837.
Abstract:
White-nose syndrome (WNS) is a fungal disease caused by Pseudogymnoascus destructans (Pd) that affects bats during hibernation. Although millions of bats have died from WNS in North America, mass mortality has not been observed among European bats infected by the fungus, leading to the suggestion that bats in Europe are immune. We tested the hypothesis that an antibody-mediated immune response can provide protection against WNS by quantifying antibodies reactive to Pd in blood samples from seven species of free-ranging bats in North America and two free-ranging species in Europe. We also quantified antibodies in blood samples from little brown myotis (Myotis lucifugus) that were part of a captive colony that we injected with live Pd spores mixed with adjuvant, as well as individuals surviving a captive Pd infection trial. Seroprevalence of antibodies against Pd, as well as antibody titers, was greater among little brown myotis than among four other species of cave-hibernating bats in North America, including species with markedly lower WNS mortality rates. Among little brown myotis, the greatest titers occurred in populations occupying regions with longer histories of WNS, where bats lacked secondary symptoms of WNS. We detected antibodies cross-reactive with Pd among little brown myotis naïve to the fungus. We observed high titers among captive little brown myotis injected with Pd. We did not detect antibodies against Pd in Pd-infected European bats during winter, and titers during the active season were lower than among little brown myotis. These results show that antibody-mediated immunity cannot explain survival of European bats infected with Pd and that little brown myotis respond differently to Pd than species with higher WNS survival rates. Although it appears that some species of bats in North America may be developing resistance to WNS, an antibody-mediated immune response does not provide an explanation for these remnant populations.
Insights
Antibody-mediated immunity does not explain white-nose syndrome (WNS) survival in European bats. Little brown myotis (Myotis lucifugus) show different responses to Pseudogymnoascus destructans (Pd) than bats with higher WNS survival rates.
Area of Science:
- Veterinary Mycology
- Bat Immunology
- Wildlife Disease Ecology
Background:
- White-nose syndrome (WNS), caused by the fungus Pseudogymnoascus destructans (Pd), has led to mass bat mortality in North America.
- European bats infected with Pd exhibit lower mortality, suggesting potential resistance or immunity.
- The role of antibody-mediated immune responses in bat survival against WNS remains unclear.
Purpose of the Study:
- To investigate the hypothesis that antibody-mediated immunity protects bats against white-nose syndrome (WNS).
- To compare antibody responses to Pd in North American and European bat populations.
- To assess the immune response in little brown myotis (Myotis lucifugus) following experimental Pd exposure.
Main Methods:
- Quantified antibodies reactive to Pd in blood samples from seven North American bat species and two European bat species.
- Analyzed antibody prevalence and titers in free-ranging bats and in captive little brown myotis experimentally exposed to Pd.
- Compared antibody levels between species and populations with varying WNS mortality rates and histories.
Main Results:
- Little brown myotis exhibited higher seroprevalence and antibody titers against Pd compared to four other North American cave-hibernating species.
- Antibody titers in little brown myotis correlated with WNS history in their regions, with higher titers in populations showing fewer secondary symptoms.
- No antibodies against Pd were detected in infected European bats during winter, and titers were lower than in little brown myotis during the active season.
Conclusions:
- Antibody-mediated immunity does not explain the survival of European bats infected with Pd.
- Little brown myotis demonstrate a distinct immune response to Pd compared to bat species with higher WNS survival rates.
- While some North American bat populations may be developing resistance to WNS, antibody-mediated immunity is not the primary mechanism explaining these remnant populations.
More Related Videos
09:18Profiling the Triacylglyceride Contents in Bat Integumentary Lipids by Preparative Thin Layer Chromatography and MALDI-TOF Mass Spectrometry
Published on: September 5, 2013
09:57Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011